Cardiorenal Actions of New Designer Natriuretic Peptide CD-NP in Experimental Heart Failure

被引:0
|
作者
Lisy, Ondrej J. [1 ]
Chen, Horng H. [1 ]
Burnett, John C., Jr. [1 ]
机构
[1] Mayo Clin, Coll Med, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A149 / A149
页数:1
相关论文
共 50 条
  • [41] Cardiorenal properties of a novel designer natriuretic peptide fusing urodilatin and C-type natriuretic peptide
    Lee, Candace Y. W.
    Sandberg, Sharon M.
    Heublein, Denise M.
    Burnett, John C., Jr.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A320 - A320
  • [42] Increase in Left Ventricular Fibrosis With LVAD Therapy and in Model of Mechanical Unloading and Potential Anti-Fibrotic Therapy of the Novel Designer Natriuretic Peptide CD-NP in vitro
    Ichiki, Tomoko
    Schirger, John A.
    Brozovich, Frank C.
    Huntley, Brenda K.
    Lisy, Ondrej
    Sangaralingham, S. Jeson
    McKie, Paul M.
    Park, Soon J.
    Burnett, John C., Jr.
    CIRCULATION, 2011, 124 (21)
  • [43] Natriuretic peptide based therapeutics for heart failure: Cenderitide: A novel first-in-class designer natriuretic peptide
    Ichiki, Tomoko
    Dzhoyashvili, Nina
    Burnett, John C., Jr.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 281 : 166 - 171
  • [44] Designer Natriuretic Peptides for Heart Failure
    Burnett, John C., Jr.
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (09) : S123 - S123
  • [45] Discovery of a novel designer natriuretic peptide, CBB-NP.
    Lee, C. Y.
    Burnett, J. C., Jr.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S2 - S2
  • [46] Novel chimeric natriuretic peptide CD-NP decreases fibrosis and improves diastolic dysfunction associated with mild renal insufficiency
    Martin, F. L.
    Mckie, P. M.
    Sangaralingham, S. J.
    Oehler, E. A.
    Korinek, J.
    Harders, G. E.
    Chen, H. H.
    Burnett, J. C.
    EUROPEAN HEART JOURNAL, 2010, 31 : 547 - 547
  • [47] A biodegradable in-situ polymer precipitation delivery system for sustained delivery of a novel chimeric natriuretic peptide CD-NP in an experimental model of myocardial infarction
    Soo Ghim Lim
    S Jeson Sangaralingham
    Syed Ameenuddin
    Fernando L Martin
    Xu Wen Ng
    Ying Ying Huang
    Subbu S Venkatraman
    John C Burnett
    Horng H Chen
    BMC Pharmacology and Toxicology, 14 (Suppl 1)
  • [48] DESIGNER CHIMERIC NATRIURETIC PEPTIDE CBA-NP REDUCES MYOCARDIAL FIBROSIS AND IMPROVES CARDIO-HUMORAL ACTIONS IN EXPERIMENTAL DIABETIC CARDIOMYOPATHY
    Ameenuddin, Syed
    Oehler, Elise A.
    Burnett, John C., Jr.
    Chen, Horng H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E362 - E362
  • [49] Design, synthesis and cardiorenal actions of a novel peptide, CDD-NP
    Lee, Candace Y. W.
    Burnett, John C., Jr.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (09): : 1132 - 1132
  • [50] Novel chimeric natriuretic peptide CBA-NP reduces cardiorenal fibrosis and improves cardiorenal function in experimental diabetic rat model
    Ameenuddin, S.
    Oehler, E. A.
    Burnett, J. C., Jr.
    Chen, H. H.
    EUROPEAN HEART JOURNAL, 2011, 32 : 358 - 358